Publications
Detailed Information
Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006
Cited 25 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Issue Date
- 2010-03
- Publisher
- KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
- Citation
- JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY; Vol.20 3; 637-642
- Keywords
- Staphylococcus aureus ; vancomycin-intermediate ; surveillance
- Abstract
- We investigated the prevalence and the molecular characteristics of vancomycin-intermediate Staphylococcus aureus (VISA) among methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 8-week period in each year from 2001 to 2006. Of 41,639 MRSAs isolated, 37,856 were screened and 169 grew on brain heart infusion agar supplemented with 4 mu g/ml vancomycin. A vancomycin MIC of 4 mu g/ml was confirmed for 33 VISA isolates of the 169 isolates. Eighteen of the 33 isolates were classified as hetero-VISA (hVISA) by the population analysis profile (PAP) method. All VISA isolates were susceptible to linezolid, tigecycline, and quinupristin dalfopristin. Most VISA isolates (MIC 4 mu g/ml) showed a PFGE C pattern with sec, seg, and sei enterotoxin genes, including ST5-SCCmec type II, or a PFGE A pattern with sea, including ST239-SCCmec type III.
- ISSN
- 1017-7825
- Language
- English
- Files in This Item:
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.